IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
about
Recent advances in understanding myelofibrosis and essential thrombocythemiaCytokine-Induced Modulation of Colorectal CancerInflammation as a Driver of Clonal Evolution in Myeloproliferative NeoplasmPathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic InflammationUnderstanding Interleukin 33 and Its Roles in Eosinophil DevelopmentIL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil HomeostasisJAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation.The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Interleukin-33 in health and disease.IL-33 is associated with unfavorable postoperative survival of patients with clear-cell renal cell carcinoma.Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cellsImmunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.STAT3 and ERK pathways are involved in cell growth stimulation of the ST2/IL1RL1 promoter.Editorial: Danger Signals Triggering Immune Response and Inflammation.JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms.Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.MYB-GATA1 fusion promotes basophilic leukaemia: involvement of interleukin-33 and nerve growth factor receptors.The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.JAK2V617F-bearing vascular niche enhances malignant hematopoietic regeneration following radiation injury.Decreased IL-33 Production Contributes to Trophoblast Cell Dysfunction in Pregnancies with Preeclampsia.Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang CytokineThe Role of IL-33/ST2 Pathway in Tumorigenesis
P2860
Q26748543-AC8DDC23-F849-464D-A522-3833F5542B09Q26752374-AD531732-B458-4D4E-A27C-FBA700883CB3Q26779936-89F41066-B0A7-4070-85E6-9FAECDD37218Q26779960-CDF2F7BA-0AA6-4B92-A213-C769728E89D1Q33621816-03C8C1BA-C982-4393-A523-C6AB80C52F26Q37402019-6D9C95C0-AAD4-42C9-BC74-A52104BD73C7Q37506624-CCF3C0B9-336A-4CC0-8B90-6256CA8C4E49Q37571181-786E77BE-1F94-4C7F-AD4A-DDEE250E5336Q37641560-8FA294C6-1ADF-467B-BC76-6355FCD9BEB9Q38753216-0FA6B407-B0B5-4027-AD3D-AE526A4434DBQ38783993-252DBAE9-6003-423F-80E4-8F890426FABAQ38957840-25AE708F-5828-4D62-9139-FFCC4A3903E9Q40881169-3FCDF48F-9B04-49EE-B516-93076F95599BQ41267861-2CB5D932-7D94-4C9F-B524-BCA513145D8EQ41573313-8E93994D-5855-4AE4-A7FD-2E04D1A96D71Q41701253-28790B27-7E5C-482F-AF2D-F0B23B3AFFDDQ42324012-B9537048-6431-427F-9E14-5E7E5A4C6ABBQ42345013-0B04B9D3-5634-423A-8F28-90265B4248C1Q42794052-E337FA99-C5C2-4932-BB8B-696FC362C989Q46419763-26EE098A-25CE-463D-86FF-43A51C8C6BEBQ47285890-0102DB7E-6429-454C-98F4-CADE6608265CQ47718005-0AC0AC87-B030-488E-920D-2FB91F3DBFF6Q48266680-761368E8-56A1-4611-A524-FB3B87EA4F60Q49442070-CD578433-869E-4B86-9C1A-D5458E5BB3C4Q52641887-36AC70A8-DF90-4A52-AC48-B5DA8E0A7670Q54996569-FB7D1A2A-67BE-4462-8AC0-9A6A9F3894EFQ55334343-69A7BF93-275B-41C0-908C-8206228E4A67Q55354182-63EA62B2-D38B-4304-BDAF-8453F2280F0AQ58707724-EADA1AD2-36F3-468C-AC98-3B1902F397D0Q58756972-0A677C77-D6B0-4689-963B-1E6681A18240
P2860
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@ast
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@en
type
label
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@ast
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@en
prefLabel
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@ast
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@en
P2093
P2860
P50
P356
P1476
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
@en
P2093
Andrew J Macpherson
Bruce Beutler
Gabriela M Baerlocher
Kathy D McCoy
Marie-Hélène Wasmer
Regula Stuber
Susumu Nakae
Xiaohong Li
P2860
P304
P356
10.1172/JCI77347
P407
P50
P577
2015-05-26T00:00:00Z